Estimation of intragastric drug solubility in the fed state: Comparison of various media with data in aspirates

Biopharmaceutics and Drug Disposition

Volumn 30, Issue 6, 2009, Pages 318-325

  Diakidou, A ^a   Vertzoni, M ^a   Dressman, J ^b   Reppas, C ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Biorelevant media; Dipyridamole; Fed stomach; Ketoconazole; Solubility

Indexed keywords

DIPYRIDAMOLE; KETOCONAZOLE; PEPSIN A; TRIACYLGLYCEROL LIPASE;

ARTICLE; CONTROLLED STUDY; DIGESTION; DRUG DETERMINATION; DRUG SOLUBILITY; FEMALE; FOOD COMPOSITION; FOOD DRUG INTERACTION; FOOD INTAKE; GASTRIC SUCTION; HUMAN; HUMAN EXPERIMENT; MALE; MILK; NORMAL HUMAN; PROCESS MODEL; REACTION TIME; STOMACH ABSORPTION; STOMACH JUICE; STOMACH PH;

ADULT; FEMALE; FOOD; FOOD-DRUG INTERACTIONS; GASTRIC JUICE; HUMANS; MALE; PHARMACEUTICAL PREPARATIONS; SATIATION; SOLUBILITY; STOMACH;

EID: 70349973780     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.670     Document Type: Article

References (20)

1. Stotzer PO, Abrahamsson H. Human postprandial gastric emptying of indigestible solids can occur unrelated to antral phase III. Neurogastroenterol Motil 2000; 12: 415-419.
2. Brouwers J, Tack J, Augustijns P. Parallel monitoring of plasma and intraluminal drug concentrations in man after oral administration of fosamprenavir in the fasted and fed state. Pharm Res 2007; 24: 1862-1869.
3. Jantratid E, Janssen N, Reppas C, Dressman JB. Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 2008; 25: 1663-1676.
4. Armand M, Borel P, Pasquier B, et al. Physicochemical characteristics of emulsions during fat digestion in human stomach and duodenum. Am J Physiol 1996; 271: G172-G183.
5. Dressman JB, Berardi RR, Dermentzoglou LC, et al. Upper gastrointestinal (GI) pH in young, healthy men and women. Pharm Res 1990; 7: 756-761.
6. Kalantzi L, Goumas K, Kalioras V, Abrahamsson B, Dressman JB, Reppas C. Characterization of the human upper gastrointestinal contents under conditions simulating bioavailability/bioequivalence studies. Pharm Res 2006; 23: 165-176.
7. Kalantzi L, Page R, Nicolaides E, Digenis G, Reppas C. In vitro methods can forecast the effects of intragastric residence on dosage form performance. Eur J Pharm Sci 2008; 33: 445-451.
8. Diakidou A, Vertzoni M, Abrahamsson B, Dressman J, Reppas C. Simulation of lipolysis and prediction of felodipine release from a matrix tablet in the fed stomach. Eur J Pharm Sci 2009; 37: 133-140.
9. Kalantzi L, Persson E, Polentarutti B, et al. Canine intestinal contents vs simulated media for the assessment of solubility of two weak bases in the human small intestinal contents. Pharm Res 2006; 23: 1373-1381.
10. Lindenberg M, Kopp S, Dressman JB. Classification of orally administered drugs on the World Health Organization Model List of Essential Medicines according to the biopharmaceutics classification system. Eur J Pharm Biopharm 2004; 58: 265-278.
11. Klein S, Butler J, Hempenstall JM, Reppas C, Dressman J. Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts. J Pharm Pharmacol 2004; 56: 605-610.
12. Guideline on the Investigation of Bioequivalence, Draft agreed by the Efficacy Working Party, Committee for Medicinal Products for Human Use, European Medicines Agency, CPMP/EWP/QWP/1401/98 Rev. 1, London 24 July 2008.
13. Dressman JB, Vertzoni M, Goumas K, Reppas C. Estimating drug solubility in the gastrointestinal tract. Adv Drug Del Rev 2007; 59: 591-602.
14. Fotaki M, Symillides M, Reppas C. Canine vs in vitro data for predicting input profiles of Lsulpiride after oral administration. Eur J Pharm Sci 2005; 26: 324-333.
15. McIlvaine TC. A buffer solution for colorimetric comparison. J Biol Chem 1921; 49: 183.
16. Gu CH, Rao D, Gandhi RB, Hilden J, Raghavan K. Using a novel multicompartment dissolution system to predict the effect of gastric pH on the oral absorption of weak bases with poor intrinsic solubility. J Pharm Sci 2005; 94: 199-208.
17. Vertzoni M, Reppas C, Archontaki H. Optimization and validation of a high-performance liquid chromatographic method with UV detection for the determination of ketoconazole in canine plasma. J Chromatogr B 2006; 839: 62-67.
18. Kohri N, Miyata N, Takahashi M, et al. Evaluation of pH dependent sustained release granules of dipyridamole by using gastric acidity controlled rabbits and human subjects. Int J Pharm 1992; 81: 49-58.
19. Esclusa Diaz MT, Gayo Otero M, Perez Marcos MB, Vila Jato JL, Torres Labandeira JJ. Preparation and evaluation of ketoconazole-beta-cyclodextrin multicomponent complexes. Int J Pharm 1996; 142: 183-187.
20. Clarysse S, Psachoulias D, Brouwers J, et al. Postprandial changes in solubilizing capacity of human intestinal fluids for BCS class II drugs. Pharm Res 2009; 26: 1456-1466.